Company Dishman Carbogen Amcis Limited

DCAL

INE385W01011

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 04:35:07 19/05/2026 pm IST			5-day change	1st Jan Change
188.28 ^INR	+0.45%		+2.78%	-23.95%

05/05	Dishman Carbogen Amcis says unit successfully completed GMP inspection by China's NMPA for Shanghai site	RE
18/03	Dishman Carbogen Amcis Ltd approves issue of up to 1 billion rupees NCDs on Private Placement basis	RE

Business description: Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Limited is engaged in offering contract research and manufacturing services (CRAMS) and the manufacture and supply of marketable molecules such as specialty chemicals, vitamins and chemicals, and disinfectants. Its segments include CRAMS and Marketable Molecules. The CRAMS segment includes Contract Research Services and Contract Manufacturing Services, which it offers to its customers. Through its CRAMS business, the Company assists drug manufacturers in the development and optimization of processes for novel drug molecules in various stages of the development process. The Marketable Molecules segment manufactures and supplies intermediates, quaternary compounds, specialty chemicals, and various products for pharmaceuticals and cosmetics. It has manufacturing and research facilities in India, Switzerland, France, the Netherlands, the United Kingdom, and China. Its subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., and others.

Number of employees: 1,106

Sales by Activity: Dishman Carbogen Amcis Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Medical Labs & Research	-	-	2.41TCr	2.62TCr	2.71TCr
Contract Research and Manufacturing Services (CRAMS)	1.43TCr	1.65TCr	-	-	-
Vitamin-D, Bulk Drugs, Quats, Speciality Chemicals and Traded Goods	479.62Cr	491.35Cr	-	-	-

See all business segments

Geographical breakdown of sales: Dishman Carbogen Amcis Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Rest of The World	1.87TCr	2.1TCr	-	-	-
India	44Cr	37Cr	-	-	-

See all geographic segments

Executive Committee: Dishman Carbogen Amcis Limited

Manager	Title	Age	Since
Arpit Janmejay Vyas CEO	Chief Executive Officer	40	07/02/2019
Harshil R. Dalal DFI	Director of Finance/CFO	44	28/11/2018
Paolo Armanino COO	Chief Operating Officer	-	-
Shrima Gaurangbhai Dave CMP	Compliance Officer	39	17/03/2017
Sandeep Jaiswal SAM	Sales & Marketing	51	20/04/2026

See DISHMAN CARBOGEN AMCIS LIMITED governance

Composition of the Board of Directors: Dishman Carbogen Amcis Limited

Director	Title	Age	Since
Deohooti Janmejay Vyas BRD	Director/Board Member	75	17/03/2017
Arpit Janmejay Vyas BRD	Director/Board Member	40	17/03/2017
Hemantkumar J. Bhatt BRD	Director/Board Member	-	01/04/2025
Margie S. Parikh BRD	Director/Board Member	61	01/04/2025
Kulin Nalinkant Shah BRD	Director/Board Member	-	13/11/2024
Dhaval Rameshchandra Shah BRD	Director/Board Member	-	12/08/2025

Composition of the Board of Directors

Shareholders: Dishman Carbogen Amcis Limited

Name	Equities	%	Valuation
Adimans Technologies LLP 59.32 %	9,30,02,442	59.32 %	180 M ₹
Mukul Mahavir Agrawal 5.496 %	86,17,000	5.496 %	17 M ₹
Massachusetts Institute of Technology Foundation 2.277 %	35,70,000	2.277 %	7 M ₹
HBM Partners AG (Investment Management) 2.19 %	34,32,857	2.19 %	7 M ₹
HSBC Asset Management (India) Pvt Ltd. 1.186 %	18,59,739	1.186 %	4 M ₹

List of DISHMAN CARBOGEN AMCIS LIMITED shareholders

Company details: Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Ltd.

Dishman Corporate House

380058, Ahmedabad

+91 27 1742 0102

http://imdcal.com

address Dishman Carbogen Amcis Limited(DCAL)

Group companies: Dishman Carbogen Amcis Limited

Name	Category and Sector
Dishman Europe Ltd. Dishman Europe Ltd. Pharmaceuticals: MajorHealth Technology Imports and markets a wide range of chemical products and pharmaceutical ingredients	Pharmaceuticals: Major
Dishman Europe Ltd. Dishman Europe Ltd. Pharmaceuticals: MajorHealth Technology Imports and markets a wide range of chemical products and pharmaceutical ingredients	Pharmaceuticals: Major
Dishman Netherlands BV Dishman Netherlands BV Pharmaceuticals: OtherHealth Technology Manufactures and sells vitamin and chemical products	Pharmaceuticals: Other
Dishman Netherlands BV Dishman Netherlands BV Pharmaceuticals: OtherHealth Technology Manufactures and sells vitamin and chemical products	Pharmaceuticals: Other

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
DISHMAN CARBOGEN AMCIS LIMITED	+0.45%	+2.78%	-12.17%	+45.50%	31Cr
ELI LILLY AND COMPANY	+3.37%	+5.63%	+34.86%	+133.26%	88TCr
JOHNSON & JOHNSON	+0.47%	+3.87%	+51.99%	+45.13%	55TCr
ABBVIE INC.	+2.08%	+5.41%	+16.16%	+49.02%	37TCr
ROCHE HOLDING AG	+0.88%	+1.06%	+24.30%	+13.90%	33TCr
NOVARTIS AG	+1.57%	+4.70%	+30.14%	+30.73%	28TCr
ASTRAZENECA PLC	+1.24%	+2.80%	+34.37%	+15.88%	28TCr
MERCK & CO., INC.	+1.49%	+2.66%	+50.20%	+0.21%	28TCr
NOVO NORDISK A/S	+0.52%	-4.17%	-32.60%	-50.00%	20TCr
AMGEN INC.	+1.96%	+0.35%	+21.42%	+47.50%	18TCr
Average	+0.59%	+1.21%	+21.87%	+33.11%	33.49TCr
Weighted average by Cap.	+0.32%	+1.70%	+30.73%	+52.78%